PDF-JanuaryEMA/118465/2012Guideline on good pharmacovigilance practice(GVP

Author : faustina-dinatale | Published Date : 2016-06-27

Draft agreed by ERMS FG20 July 2012 Draft adopted by Executive Director25 July 2012 Start of public consultation6 July 2012 End of consultation deadline for comments21

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "JanuaryEMA/118465/2012Guideline on good ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

JanuaryEMA/118465/2012Guideline on good pharmacovigilance practice(GVP: Transcript

Draft agreed by ERMS FG20 July 2012 Draft adopted by Executive Director25 July 2012 Start of public consultation6 July 2012 End of consultation deadline for comments21 September 2012 Revised draft f. New challenges for WHO. Dr Shanthi Pal. . Group Lead, Medicines Safety . . Director/EMP . K. De . Joncheere. Coordinator PAU. G. Forte. Head/RHT. L.Rago. Coordinator/PHI. M Zafar. Coordinator /PQT. Draft Revision 1 agreed by ERMS FG29 May 2013 Draft Revision 1 adopted by Executive Director6 June 2013 Released for public consultation7 June 2013 nd of consultation (deadline for comments)5 August 2 JAMASOFT2017. 1. Social. Pharmacy. Pharmacoepidemiology. Pharmacovigilance. JAMASOFT2017. 2. P. armacovigilance. system collects data . throughout the . lifecycle . of each . medicinal. . product. , MD. Pfizer, India. DISCLAIMER. Overview. Introduction & Terminology. Why Pharmacovigilance?. Pharmacovigilance Practices. : International & Indian. PVPI. Drug Safety Issues in Clinical Trials . & . Adverse Drug Reactions . Reporting systems. Dr. . Habab. Khalid . Elkheir. B.Pharm. ., . M.Pharm. ., PhD . ISOP. ISPE. IUATLD. SSCP. 11/28/2017. Habab khalid Elkheir. Objectives of the workshop. Open Access Publications. and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information on Sciences and technology ‘Open Access’, OMICS Group publishes 500 online open access . Monitoring the safety of medicines. Pharmacovigilance is the science and practices related to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problem. Dr Shanthi Pal. . Group Lead, Medicines Safety . . Director/EMP . K. De . Joncheere. Coordinator PAU. G. Forte. Head/RHT. L.Rago. Coordinator/PHI. M Zafar. Coordinator /PQT. Coordinator RSS. N Dellepiane. NOT. regulated by EU legislation and no uniform definition is available.. Off-label use of a medicine is the use of an authorised medicine by a healthcare professional to treat a patient in a way not covered by Marketing Authorisation (MA) and detailed in the Summary of Product Characteristics (. Prospects and Challenges of Providing Pharmacovigilance Services in Resource Limited Countries Avong YK 1 , Jatau B 1 , Ekong E 1 , Ndembi N 1 , Okuma J 1 , Obieze AI 2 , Osakwe A 2 , Prospects and Challenges of Providing Pharmacovigilance Services in Resource Limited Countries Avong YK 1 , Jatau B 1 , Ekong E 1 , Ndembi N 1 , Okuma J 1 , Obieze AI 2 , Osakwe A 2 , 1February20211EMA/419982/2019-2Guideline on good pharmacovigilance practices GVP3Module XVI AddendumIIMethods for effectiveness evaluation4Date for coming into effect of first version 1 March 2014Date No medicine is without . risk and the. . benefits of . a medicine must always be weighed up against its risks. . The . balance of benefits and risks should be effectively considered and must not be left to chance. Authors: . 1. Juliet Jokwiro, . 1. Nicole Chekudambune-Kawaza, . 1. Kenny Sithole, . 1. Bongani Dube, . 2. Charles Sandy, . 2. Manners Ncube, . 2 . Regina Mubau,. 2. Chlorata Gwanzura, . 2. Kwenziweyinkosi Ndlovu, .

Download Document

Here is the link to download the presentation.
"JanuaryEMA/118465/2012Guideline on good pharmacovigilance practice(GVP"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.